Efficacy of varenicline, an alpha4ß2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial [corrected] [published erratum appears in JAMA 2006 Sep 20;296(11):1355]. - Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR; Varenicline Phase 3 Study Group; Jorenby, Douglas E; Hays, J Taylor; et al. (JAMA: Journal of the American Medical Association, 2006)